BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9861342)

  • 1. Expression of bcl-2 oncoprotein in Indian oral squamous cell carcinomas.
    Kannan K; Latha PN; Shanmugam G
    Oral Oncol; 1998 Sep; 34(5):373-6. PubMed ID: 9861342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity.
    Jordan RC; Catzavelos GC; Barrett AW; Speight PM
    Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):394-400. PubMed ID: 9039223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis-associated proteins and the development of oral squamous cell carcinoma.
    Schoelch ML; Le QT; Silverman S; McMillan A; Dekker NP; Fu KK; Ziober BL; Regezi JA
    Oral Oncol; 1999 Jan; 35(1):77-85. PubMed ID: 10211314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of bcl-2 oncoprotein in Indian oral cell carcinomas.
    Saranath D
    Oral Oncol; 1999 May; 35(3):349-50. PubMed ID: 10621859
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India.
    Teni T; Pawar S; Sanghvi V; Saranath D
    Pathol Oncol Res; 2002; 8(2):109-14. PubMed ID: 12172574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
    de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
    Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
    Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
    Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity.
    Staibano S; Mignogna MD; Lo Muzio L; Di Alberti L; Di Natale E; Lucariello A; Mezza E; Bucci E; DeRosa G
    Hum Pathol; 1998 Nov; 29(11):1189-94. PubMed ID: 9824094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance.
    Alam M; Kashyap T; Pramanik KK; Singh AK; Nagini S; Mishra R
    Clin Oral Investig; 2017 Dec; 21(9):2721-2731. PubMed ID: 28233171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma.
    Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
    Histopathology; 2010 Aug; 57(2):304-16. PubMed ID: 20716171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk human papillomavirus (HPV) is not associated with p53 and bcl-2 expression in oral squamous cell carcinomas.
    Oliveira MC; Soares RC; Pinto LP; Souza LB; Medeiros SR; Costa Ade L
    Auris Nasus Larynx; 2009 Aug; 36(4):450-6. PubMed ID: 19124208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
    Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
    Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of Bcl-2 in oral epithelial dysplasia and oral squamous cell carcinoma.
    Juneja S; Chaitanya NB; Agarwal M
    Indian J Cancer; 2015; 52(4):505-10. PubMed ID: 26960459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases.
    Hague A; Packham G; Huntley S; Shefford K; Eveson JW
    J Pathol; 2002 May; 197(1):60-71. PubMed ID: 12081206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bcl-2 in oral squamous cell carcinoma: an immunohistochemical study of 90 cases with clinico-pathological correlations.
    Lo Muzio L; Mignogna MD; Pannone G; Rubini C; Grassi R; Nocini PF; Ferrari F; Serpico R; Favia G; De Rosa G; Maiorano E
    Oncol Rep; 2003; 10(2):285-91. PubMed ID: 12579259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx.
    Veneroni S; Silvestrini R; Costa A; Salvatori P; Faranda A; Molinari R
    Oral Oncol; 1997 Nov; 33(6):408-13. PubMed ID: 9509124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 expression in oral cancer: observations of a South Indian study.
    Pillay M; Vasudevan DM; Rao CP; Vidya M
    J Exp Clin Cancer Res; 2003 Sep; 22(3):447-51. PubMed ID: 14582705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG; Johnston CF; Sloan JM; Buchanan KD
    J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype.
    De Angelis PM; Stokke T; Thorstensen L; Lothe RA; Clausen OP
    Mol Pathol; 1998 Oct; 51(5):254-61. PubMed ID: 10193519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.